Policy decisions are rarely as straightforward as they appear, even when cloaked in the certainty of scientific data. This is particularly true in the complex world of environmental health, where the gap between scientific understanding and regulatory action is often where the most significant, yet least examined, choices are made. The U.S. Environmental Protection Agency's (EPA) recent efforts to establish national drinking water standards for per- and polyfluoroalkyl substances (PFAS) offer a stark illustration of this dynamic.
In March 2023, the EPA proposed the first-ever national drinking water standards for six PFAS compounds, including Maximum Contaminant Levels (MCLs) of 4 parts per trillion (ppt) for PFOA and PFOS. These numbers, seemingly precise, are not simply direct translations of scientific consensus. They emerge from a deliberative process that interprets evolving toxicology, weighs exposure risks, and ultimately makes policy choices about acceptable levels of public health protection. This process of translation is where the real policy-making occurs, often far from the public eye.
The scientific understanding of PFAS is still developing. Studies consistently show that even very low levels of exposure can be harmful, with many researchers suggesting there is no truly "safe" level. This scientific uncertainty — the fuzzy edge where data is incomplete or conflicting — presents a critical juncture for regulators. Do they lean into a highly precautionary approach, setting standards at the lowest detectable levels or even seeking outright bans? Or do they balance potential health risks against feasibility, economic impacts, and the existing industrial landscape? The numbers the EPA ultimately proposes reflect an answer to these questions, an answer that is as much a regulatory posture as a scientific finding.
This policy posture becomes evident when comparing the U.S. approach to that of other nations. In the European Union, for example, the approach to PFAS regulation has often been broader and more precautionary. Some EU member states and the European Chemicals Agency (ECHA) are moving towards comprehensive restrictions on entire classes of PFAS, driven by the "grouping" principle and a more explicit embrace of the precautionary principle. While the EPA focuses on specific compounds and sets individual limits, the EU's strategy often targets total PFAS in drinking water or seeks to phase out non-essential uses across industrial sectors. These differing regulatory outcomes are not due to different scientific facts, but rather different policy interpretations of those facts, different assumptions about uncertainty, and different societal tolerances for risk.
The decision to set an MCL at 4 ppt for PFOA and PFOS, while a significant step for the U.S., is therefore a specific policy choice. It’s a choice about how much scientific uncertainty to tolerate, how to discount future risks, and what level of exposure is deemed acceptable for millions of Americans. It is a decision that, when viewed through the lens of international comparison, reveals itself not as an inevitable outcome of scientific data, but as a contingent answer to a deeply political question, dressed in the language of chemistry. Understanding these underlying mechanisms — the points where science ends and policy choices begin — is essential to grasping how our world is shaped by decisions that could have gone another way.